W. L. Gore & Associates, Inc. Reacts to RESPECT Trial Results

Published: Oct 26, 2012

FLAGSTAFF, Ariz. & MIAMI--(BUSINESS WIRE)--W. L. Gore & Associates (Gore) today responded to initial results reported in St. Jude Medical, Inc.’s RESPECT clinical trial. The RESPECT study investigated whether transcatheter closure of PFO using St Jude’s AMPLATZER® PFO Occluder device is safe and effective compared to best medical therapy in the prevention of recurrent cryptogenic stroke. Gore is concurrently conducting its Gore REDUCE Clinical Study using both the GORE® HELEX® Septal Occluder and, as reported earlier this week, the new GORE® Septal Occluder, in patients with PFO and a history of cryptogenic stroke or imaging-confirmed transient ischemic attack (TIA).

Back to news